KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $489,000 | -98.3% | 46,470 | -97.5% | 0.02% | -98.1% |
| Q4 2020 | $28,217,000 | +20.5% | 1,822,781 | +13.7% | 0.94% | -2.8% |
| Q3 2020 | $23,407,000 | -0.7% | 1,603,253 | +28.9% | 0.96% | -6.2% |
| Q2 2020 | $23,565,000 | +17.3% | 1,244,211 | +19.0% | 1.03% | -11.6% |
| Q1 2020 | $20,085,000 | +109.0% | 1,045,548 | +108.6% | 1.16% | +186.2% |
| Q4 2019 | $9,609,000 | -33.3% | 501,253 | -66.5% | 0.41% | -39.6% |
| Q3 2019 | $14,397,000 | +62.8% | 1,496,583 | +1.4% | 0.67% | +89.3% |
| Q2 2019 | $8,843,000 | +0.4% | 1,476,234 | -2.1% | 0.36% | -0.8% |
| Q1 2019 | $8,807,000 | -35.5% | 1,508,094 | +3.5% | 0.36% | -46.6% |
| Q4 2018 | $13,647,000 | +15.5% | 1,456,473 | +109.8% | 0.67% | +54.6% |
| Q3 2018 | $11,820,000 | +23.9% | 694,068 | +23.6% | 0.43% | +20.6% |
| Q2 2018 | $9,537,000 | – | 561,317 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |